Showing 1,001 - 1,020 results of 9,646 for search 'significant ((((((step decrease) OR (greater decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.62s Refine Results
  1. 1001

    Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

    Published 2024
    “…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …”
  2. 1002
  3. 1003
  4. 1004
  5. 1005
  6. 1006

    S1 File - by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  7. 1007
  8. 1008

    Confusion matrix for ClinicalBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  9. 1009

    Confusion matrix for LastBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  10. 1010

    Student model architecture. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  11. 1011

    Configuration of the LastBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  12. 1012

    Confusion matrix for DistilBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  13. 1013

    ROC curve for LastBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  14. 1014

    Sample Posts from the ADHD dataset. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  15. 1015

    Top-level overview for ADHD classification study. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”
  16. 1016

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  17. 1017

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  18. 1018

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  19. 1019
  20. 1020